Jump to content
RemedySpot.com

Treatment Update: Small Molecules in Development for Chronic Hepatitis C

Rate this topic


Guest guest

Recommended Posts

Guest guest

CME-Certified Treatment UpdateThe Future of HCV:Small Molecules in Development

for Chronic Hepatitis C

This Treatment Update includes 3 CME-certified educational modules that review

the latest data in small-molecule anti-HCV agents in development. To access this

program, click here or select from the modules below.

Program Director: T. Chung, MD

Clinical Need and Therapeutic Targets for New HCV Agents

E. Sherman, MD, PhD, explores the clinical need for novel therapies for

chronic hepatitis C. He also reviews the hepatitis C virus life cycle,

highlighting the limited understanding of the mechanisms of action of current

agents and the rationale behind specific targeting of the novel small agents in

development. Click here.

Investigational Small Molecule Agents for the Treatment of Chronic Hepatitis C

In this module, L. , MD, discusses the latest efficacy and safety data

on small-molecule, specifically targeted, anti-HCV agents in development. To

review this CME-certified activity, click here.

Current Issues in the Development and Clinical Role of Novel Agents for Chronic

Hepatitis C

In this module, T. Chung, MD, explores key issues in the development and

potential future clinical role of small-molecule anti–HCV agents with particular

emphasis on HCV drug resistance. To review this CME-certified activity, click

here.

This Treatment Update is located online

at:http://clinicaloptions.com/Hepatitis/Treatment%20Updates/Small%20Molecule%20H\

CV%20Agents.aspx

Jointly sponsored by Postgraduate Institute for Medicineand Clinical Care

Options, LLC.

Clinical Need and Therapeutic Targets for New HCV AgentsRelease date: April 11,

2007Expiration date: April 10, 2008

Investigational Small Molecule Agents for the Treatment of Chronic Hepatitis

CRelease date: July 16, 2007Expiration date: July 15, 2008

Current Issues in the Development and Clinical Role of Novel Agents for Chronic

Hepatitis CRelease date: August 27, 2007Expiration date: August 26, 2008

Supported by an independent educational grant from Roche.

Unsubscribe | Not a member yet? Click here | RSS | Hepatitis Podcasts |

Bookstore

To ensure you receive Clinical Care Options educational materials by

email,please add info@... to your contacts or address book.

Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

_________________________________________________________________

Need to know the score, the latest news, or you need your Hotmail®-get your

" fix " .

http://www.msnmobilefix.com/Default.aspx

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...